Due to the complexity of biological processes, developing model-based strategies for monitoring, optimization and control is nontrivial. Hybrid neural models, combining mechanistic modeling with artificial neural networks, have been reported as powerful tools for bioprocess applications. In this paper, a systematic literature review is presented focused on the application of hybrid neural models to bioprocesses by Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) over the last 30 years. This analysis showed that hybrid neural modeling has covered a wide range of microbial processes, animal cells, mixed microbial cultures, and enzyme biocatalysis. Hybrid neural models have been mainly applied for predictive modeling/process analysis, process monitoring/software sensors, open- and closed-loop control, batch-to-batch control, model predictive control, intensified design of experiments, process analytical technology, quality-by-design, and more recently, digital twins. Hybrid modeling experienced a decline in the number of publications after a peak in 2004 and is now surging again. A “model scale” research gap was identified, which will likely narrow by a better integration with deep learning and systems biology in the near future. The biopharma sector is currently a major driver but applications to biologics quality attributes (e.g. glycosylation), new modalities and downstream unit operations are significant research gaps.

Due to the complexity of biological transformations, developing model-based strategies to optimize and control bioprocesses is nontrivial. Hybrid models combining a mechanistic description of known influential factors with machine learning to infer the missing influential factors from data have been reported as powerful tools for bioprocesses applications. The artificial neural network is one of the most popular machine learning methods in this case. This paper presents a systematic literature review by computerized search across two databases: Scopus and Web of Science, and backward citation. The PRISMA method was applied to selecting the publications and 159 research articles were categorized as hybrid model applications to bioprocesses problems. It was found that hybrid models were mainly applied in upstream operation steps with a predominance of bioreaction steps. In downstream processing, chromatography appeared as a more recent research topic, with a relatively small number of publications. Furthermore, holistic hybrid modeling applications that integrate data and knowledge from several bioprocess steps will likely emerge in the future, enabling better optimization and control of the bioprocess’s platform. The combination of other machine learning methods with the hybrid neural network model is another opportunity that could improve the output of the model.

Objective To evaluate the accuracy of 35-37 weeks‘ ultrasound for fetal growth restriction (FGR) detection and the impact of 30th-33rd weeks vs 35th-37th weeks ultrasound on perinatal outcomes. Design A prospective randomized trial Setting Tertiary referral hospital in Portugal. Population Low risk pregnant women Methods We enrolled 1061 women: 513 in the control group (ultrasound at 30th-33rd weeks) and 548 in the study group (with an additional ultrasound at 35th-37th weeks). FGR was defined as an estimated fetal weight (EFW) below 10th percentile. We calculated the overall accuracy of the 35-37 weeks’ ultrasound and compared perinatal outcomes between both groups. Main outcome measure Detection of late FGR Results The ultrasound at 35-37 weeks had an overall accuracy of FGR screening of 94%. Spearman’s correlation coefficient between EFW and birthweight centile was higher for at 35-37 weeks’ ultrasound (ρ = 0.75) compared with 30-33 weeks’ ultrasound (ρ = 0.44). The study group had a lower rate of operative vaginal deliveries (24.4% vs 39.3%, p = 0.005) and cesarean deliveries for nonreassuring fetal status (16.8% vs 38.8%, p < 0.001). For FGR prediction, the area under the receiver-operating characteristics curve of EFW centile at 35-37 weeks’ ultrasound was 0.90 (95% CI, 0.86-0.95). Conclusions A later ultrasound (35-37 weeks) had a higher correlation between EFW and birthweight centiles and was associated with a lower rate of cesarean and operative deliveries for nonreassuring fetal status compared to an earlier ultrasound, which reinforces that antenatal identification of FGR allows close monitoring and appropriate management.